California Public Employees Retirement System Sarepta Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$135 Billion
Q2 2024

A detailed history of California Public Employees Retirement System transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 151,851 shares of SRPT stock, worth $18.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

151,851

Previous 123,785 22.67%

Holding current value

$18.6 Million

Previous $16 Million 49.72%

% of portfolio

0.02%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $3.18 Million - $4.6 Million	28,066 Added 22.67%	151,851 $24 Million
Q1 2024 Apr 30, 2024	SELL	$93.7 - $141.53 $243,713 - $368,119	-2,601 Reduced 2.06%	123,785 $16 Million
Q4 2023 Feb 01, 2024	SELL	$67.31 - $124.76 $2.56 Million - $4.75 Million	-38,071 Reduced 23.15%	126,386 $12.2 Million
Q3 2023 Nov 02, 2023	SELL	$102.5 - $123.59 $374,022 - $450,979	-3,649 Reduced 2.17%	164,457 $19.9 Million
Q2 2023 Aug 09, 2023	BUY	$106.4 - $157.19 $134,064 - $198,059	1,260 Added 0.76%	168,106 $19.3 Million
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $2.98 Million - $3.96 Million	-25,365 Reduced 13.2%	166,846 $23 Million
Q4 2022 Feb 08, 2023	BUY	$100.86 - $132.13 $95,514 - $125,127	947 Added 0.5%	192,211 $24.9 Million
Q3 2022 Nov 09, 2022	BUY	$75.71 - $119.24 $1.72 Million - $2.71 Million	22,766 Added 13.51%	191,264 $21.1 Million
Q2 2022 Aug 10, 2022	SELL	$62.69 - $88.44 $273,014 - $385,156	-4,355 Reduced 2.52%	168,498 $12.6 Million
Q1 2022 May 04, 2022	SELL	$63.15 - $90.42 $332,042 - $475,428	-5,258 Reduced 2.95%	172,853 $13.5 Million
Q4 2021 Feb 10, 2022	BUY	$77.28 - $99.42 $678,827 - $873,305	8,784 Added 5.19%	178,111 $16 Million
Q3 2021 Nov 10, 2021	BUY	$65.97 - $92.48 $998,324 - $1.4 Million	15,133 Added 9.81%	169,327 $15.7 Million
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $1.04 Million - $1.3 Million	-14,970 Reduced 8.85%	154,194 $12 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $909,627 - $2.13 Million	-12,590 Reduced 6.93%	169,164 $12.6 Million
Q4 2020 Feb 02, 2021	BUY	$125.56 - $178.74 $1.35 Million - $1.92 Million	10,735 Added 6.28%	181,754 $31 Million
Q3 2020 Nov 05, 2020	BUY	$127.12 - $172.34 $2.46 Million - $3.33 Million	19,350 Added 12.76%	171,019 $24 Million
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $648,117 - $1.2 Million	6,969 Added 4.82%	151,669 $24.3 Million
Q1 2020 May 12, 2020	SELL	$82.38 - $131.64 $4.14 Million - $6.62 Million	-50,277 Reduced 25.79%	144,700 $14.2 Million
Q4 2019 Jan 27, 2020	BUY	$76.53 - $135.58 $4.97 Million - $8.8 Million	64,877 Added 49.87%	194,977 $25.2 Million
Q3 2019 Oct 31, 2019	BUY	$72.81 - $156.91 $2.58 Million - $5.55 Million	35,400 Added 37.38%	130,100 $9.8 Million
Q2 2019 Aug 15, 2019	SELL	$112.21 - $151.95 $3 Million - $4.06 Million	-26,720 Reduced 22.01%	94,700 $14.4 Million
Q1 2019 May 03, 2019	SELL	$106.67 - $151.68 $400,652 - $569,710	-3,756 Reduced 3.0%	121,420 $14.5 Million
Q4 2018 Feb 08, 2019	SELL	$97.32 - $148.76 $463,437 - $708,395	-4,762 Reduced 3.66%	125,176 $13.7 Million
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $312,490 - $437,692	2,710 Added 2.13%	129,938 $21 Million
Q2 2018 Aug 15, 2018	SELL	$71.74 - $153.69 $1.32 Million - $2.82 Million	-18,376 Reduced 12.62%	127,228 $16.8 Million
Q1 2018 May 11, 2018	SELL	$54.02 - $82.27 $59,205 - $90,167	-1,096 Reduced 0.75%	145,604 $10.8 Million
Q4 2017 Feb 06, 2018	BUY	$47.64 - $56.75 $181,032 - $215,650	3,800 Added 2.66%	146,700 $8.16 Million
Q3 2017 Nov 15, 2017	BUY	$35.73 - $47.15 $5.11 Million - $6.74 Million	142,900	142,900 $6.48 Million

Others Institutions Holding SRPT

# of Institutions

560

Shares Held

85.5M

Call Options Held

3.67M

Put Options Held

1.75M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.7B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account

California Public Employees Retirement System Sarepta Therapeutics, Inc. Transaction History